Amgen Joins AI/ML Gold Rush With Generate Deal

 
• By Alaric DeArment
  
AI hand reaches
Amgen and Generate announced a deal worth potentially $1.9bn focused on AI/ML in drug development • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from AI

More from Digital Technologies